Skip to main content
Erschienen in: Osteoporosis International 4/2009

01.04.2009 | Original Article

Association between iron overload and osteoporosis in patients with hereditary hemochromatosis

verfasst von: L. Valenti, M. Varenna, A. L. Fracanzani, V. Rossi, S. Fargion, L. Sinigaglia

Erschienen in: Osteoporosis International | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Summary

In 87 patients with hereditary hemochromatosis, osteoporosis was detected in 25%, and osteopenia in 41%. Bone mineral density was independently associated with BMI, ALP levels, hypogonadism/menopause, and the amount of iron removed to reach depletion, but not with cirrhosis. Osteoporosis is influenced by iron overload in hemochromatosis.

Introduction

To analyze prevalence, clinical characteristics and genetic background associated with osteoporosis in a retrospective study in Italian patients with hereditary hemochromatosis (HHC).

Methods

In 87 consecutive patients with HHC, bone mineral density was systematically evaluated by dual energy x-ray absorptiometry of the lumbar spine (n = 87) and femoral neck (n = 66).

Results

Osteoporosis was detected in 22 (25.3%), and osteopenia in 36 (41.4%) patients. Mean Z scores were −0.92 ± 1.42 at lumbar spine and −0.35 ± 1.41 at femoral neck. Lumbar spine T-score was independently associated with total ALP (p = 0.002), hypogonadism/menopause (p = 0.026), and iron overload (p = 0.033 for ferritin and p = 0.017 for iron removed). We observed a borderline significance for BMI (p = 0.069) and smoking status (p = 0.086). Lumbar spine osteoporosis was independently associated with lower BMI (OR 0.73, 95% CI 0.54–0.94), total ALP (OR 1.17, 95% CI 1–1.39 per 10 unit increase) and the amount of iron removed (OR 1.53, 95% CI 1–2.5 per 5 g increase). HFE genotypes did not differ between patients with and without osteoporosis.

Conclusions

Osteoporosis is observed in a quarter of unselected patients with HHC, independently of the genetic background, and is associated with ALP, hypogonadism, body weight, and severity of iron overload.
Literatur
1.
Zurück zum Zitat Pietrangelo A (2004) Hereditary hemochromatosis-a new look at an old disease. N Engl J Med 350:2383–2397PubMedCrossRef Pietrangelo A (2004) Hereditary hemochromatosis-a new look at an old disease. N Engl J Med 350:2383–2397PubMedCrossRef
2.
Zurück zum Zitat Feder JN, Gnirke A, Thomas W et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408PubMedCrossRef Feder JN, Gnirke A, Thomas W et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408PubMedCrossRef
3.
Zurück zum Zitat Camaschella C (2005) Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders. Blood 106:3710–3717PubMedCrossRef Camaschella C (2005) Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders. Blood 106:3710–3717PubMedCrossRef
4.
Zurück zum Zitat Valenti L, Pulixi EA, Arosio P et al (2007) Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis. Haematologica 92:1037–1042PubMedCrossRef Valenti L, Pulixi EA, Arosio P et al (2007) Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis. Haematologica 92:1037–1042PubMedCrossRef
5.
Zurück zum Zitat Nagashima M, Kudo M, Chung H et al (2006) Regulatory failure of serum prohepcidin levels in patients with hepatitis C. Hepatol Res 36:288–293PubMedCrossRef Nagashima M, Kudo M, Chung H et al (2006) Regulatory failure of serum prohepcidin levels in patients with hepatitis C. Hepatol Res 36:288–293PubMedCrossRef
6.
Zurück zum Zitat Harrison-Findik DD, Klein E, Crist C et al (2007) Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol. Hepatology 46:1979–1985PubMedCrossRef Harrison-Findik DD, Klein E, Crist C et al (2007) Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol. Hepatology 46:1979–1985PubMedCrossRef
7.
Zurück zum Zitat Sinigaglia L, Fargion S, Fracanzani AL et al (1997) Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. J Rheumatol 24:1809–1813PubMed Sinigaglia L, Fargion S, Fracanzani AL et al (1997) Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. J Rheumatol 24:1809–1813PubMed
8.
Zurück zum Zitat Guggenbuhl P, Deugnier Y, Boisdet JF et al (2005) Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int 16:1809–1814PubMedCrossRef Guggenbuhl P, Deugnier Y, Boisdet JF et al (2005) Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int 16:1809–1814PubMedCrossRef
9.
Zurück zum Zitat Conte D, Caraceni MP, Duriez J et al (1989) Bone involvement in primary hemochromatosis and alcoholic cirrhosis. Am J Gastroenterol 84:1231–1234PubMed Conte D, Caraceni MP, Duriez J et al (1989) Bone involvement in primary hemochromatosis and alcoholic cirrhosis. Am J Gastroenterol 84:1231–1234PubMed
10.
Zurück zum Zitat Diamond T, Stiel D, Posen S (1989) Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors? Ann Intern Med 110:430–436PubMed Diamond T, Stiel D, Posen S (1989) Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors? Ann Intern Med 110:430–436PubMed
11.
Zurück zum Zitat Diamond T, Pojer R, Stiel D et al (1991) Does iron affect osteoblast function? Studies in vitro and in patients with chronic liver disease. Calcif Tissue Int 48:373–379PubMedCrossRef Diamond T, Pojer R, Stiel D et al (1991) Does iron affect osteoblast function? Studies in vitro and in patients with chronic liver disease. Calcif Tissue Int 48:373–379PubMedCrossRef
12.
Zurück zum Zitat de Vernejoul MC, Pointillart A, Golenzer CC et al (1984) Effects of iron overload on bone remodeling in pigs. Am J Pathol 116:377–384PubMed de Vernejoul MC, Pointillart A, Golenzer CC et al (1984) Effects of iron overload on bone remodeling in pigs. Am J Pathol 116:377–384PubMed
13.
Zurück zum Zitat Diamond T, Stiel D, Posen S (1991) Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis. J Bone Miner Res 6:39–43PubMedCrossRef Diamond T, Stiel D, Posen S (1991) Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis. J Bone Miner Res 6:39–43PubMedCrossRef
14.
Zurück zum Zitat Angelopoulos NG, Goula AK, Papanikolaou G et al (2006) Osteoporosis in HFE2 juvenile hemochromatosis. A case report and review of the literature. Osteoporos Int 17:150–155PubMedCrossRef Angelopoulos NG, Goula AK, Papanikolaou G et al (2006) Osteoporosis in HFE2 juvenile hemochromatosis. A case report and review of the literature. Osteoporos Int 17:150–155PubMedCrossRef
15.
Zurück zum Zitat Valenti L, Fracanzani AL, Rossi V et al (2008) The hand arthropathy of hereditary hemochromatosis is strongly associated with iron overload. J Rheumatol 35:153–158PubMed Valenti L, Fracanzani AL, Rossi V et al (2008) The hand arthropathy of hereditary hemochromatosis is strongly associated with iron overload. J Rheumatol 35:153–158PubMed
16.
Zurück zum Zitat Guillygomarc’h A, Mendler MH, Moirand R et al (2001) Venesection therapy of insulin resistance-associated hepatic iron overload. J Hepatol 35:344–349PubMedCrossRef Guillygomarc’h A, Mendler MH, Moirand R et al (2001) Venesection therapy of insulin resistance-associated hepatic iron overload. J Hepatol 35:344–349PubMedCrossRef
17.
Zurück zum Zitat Scheuer PG, Williams R, Muir AR (1962) Hepatic pathology in relatives of patients with hemochromatosis. J Pathol Bacteriol 84:1–85CrossRef Scheuer PG, Williams R, Muir AR (1962) Hepatic pathology in relatives of patients with hemochromatosis. J Pathol Bacteriol 84:1–85CrossRef
18.
Zurück zum Zitat Barry M, Sherlock S (1971) Measurement of liver iron concentration in needle biopsy specimens. Lancet 1:100–103PubMedCrossRef Barry M, Sherlock S (1971) Measurement of liver iron concentration in needle biopsy specimens. Lancet 1:100–103PubMedCrossRef
19.
Zurück zum Zitat Sampietro M, Piperno A, Lupica L et al (1998) High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology 27:181–184PubMedCrossRef Sampietro M, Piperno A, Lupica L et al (1998) High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology 27:181–184PubMedCrossRef
20.
Zurück zum Zitat Adams PC, Reboussin DM, Barton JC et al (2005) Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 352:1769–1778PubMedCrossRef Adams PC, Reboussin DM, Barton JC et al (2005) Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 352:1769–1778PubMedCrossRef
21.
Zurück zum Zitat McDermott JH, Walsh CH (2005) Hypogonadism in hereditary hemochromatosis. J Clin Endocrinol Metab 90:2451–2455PubMedCrossRef McDermott JH, Walsh CH (2005) Hypogonadism in hereditary hemochromatosis. J Clin Endocrinol Metab 90:2451–2455PubMedCrossRef
22.
Zurück zum Zitat Cundy T, Bomford A, Butler J et al (1989) Hypogonadism and sexual dysfunction in hemochromatosis: the effects of cirrhosis and diabetes. J Clin Endocrinol Metab 69:110–116PubMedCrossRef Cundy T, Bomford A, Butler J et al (1989) Hypogonadism and sexual dysfunction in hemochromatosis: the effects of cirrhosis and diabetes. J Clin Endocrinol Metab 69:110–116PubMedCrossRef
23.
Zurück zum Zitat Group WHOs (1994) Osteoporosis. In: (eds)(1994) Assesment of fracture risk and its application to screening for post-menopausal osteoporosis. WHO technical report series 843. WHO, Geneva pp Group WHOs (1994) Osteoporosis. In: (eds)(1994) Assesment of fracture risk and its application to screening for post-menopausal osteoporosis. WHO technical report series 843. WHO, Geneva pp
24.
Zurück zum Zitat Pedrazzoni M, Girasole G, Bertoldo F et al (2003) Definition of a population-specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS). Osteoporos Int 14:978–982PubMedCrossRef Pedrazzoni M, Girasole G, Bertoldo F et al (2003) Definition of a population-specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS). Osteoporos Int 14:978–982PubMedCrossRef
25.
Zurück zum Zitat Varenna M, Binelli L, Zucchi F et al (1997) Is the metatarsal fracture in postmenopausal women an osteoporotic fracture? A cross-sectional study on 113 cases. Osteoporos Int 7:558–563PubMedCrossRef Varenna M, Binelli L, Zucchi F et al (1997) Is the metatarsal fracture in postmenopausal women an osteoporotic fracture? A cross-sectional study on 113 cases. Osteoporos Int 7:558–563PubMedCrossRef
26.
Zurück zum Zitat Mandelli C, Cesarini L, Piperno A et al (1992) Saturability of hepatic iron deposits in genetic hemochromatosis. Hepatology 16:956–959PubMedCrossRef Mandelli C, Cesarini L, Piperno A et al (1992) Saturability of hepatic iron deposits in genetic hemochromatosis. Hepatology 16:956–959PubMedCrossRef
27.
Zurück zum Zitat Cundy T, Butler J, Bomford A et al (1993) Reversibility of hypogonadotrophic hypogonadism associated with genetic haemochromatosis. Clin Endocrinol (Oxf) 38:617–620CrossRef Cundy T, Butler J, Bomford A et al (1993) Reversibility of hypogonadotrophic hypogonadism associated with genetic haemochromatosis. Clin Endocrinol (Oxf) 38:617–620CrossRef
28.
Zurück zum Zitat Szulc P, Montella A, Delmas PD (2007) High bone turnover is associated with accelerated bone loss but not with increased fracture risk in men aged 50 and over - prospective MINOS study. Ann Rheum Dis Szulc P, Montella A, Delmas PD (2007) High bone turnover is associated with accelerated bone loss but not with increased fracture risk in men aged 50 and over - prospective MINOS study. Ann Rheum Dis
29.
Zurück zum Zitat Pratelli L, Verri E, Fortini M et al (2006) Chelation therapy and bone metabolism markers in thalassemia major. J Pediatr Endocrinol Metab 19:1335–1342PubMed Pratelli L, Verri E, Fortini M et al (2006) Chelation therapy and bone metabolism markers in thalassemia major. J Pediatr Endocrinol Metab 19:1335–1342PubMed
30.
Zurück zum Zitat Salama OS, Al-Tonbary YA, Shahin RA et al (2006) Unbalanced bone turnover in children with beta-thalassemia. Hematology 11:197–202PubMedCrossRef Salama OS, Al-Tonbary YA, Shahin RA et al (2006) Unbalanced bone turnover in children with beta-thalassemia. Hematology 11:197–202PubMedCrossRef
Metadaten
Titel
Association between iron overload and osteoporosis in patients with hereditary hemochromatosis
verfasst von
L. Valenti
M. Varenna
A. L. Fracanzani
V. Rossi
S. Fargion
L. Sinigaglia
Publikationsdatum
01.04.2009
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 4/2009
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-008-0701-4

Weitere Artikel der Ausgabe 4/2009

Osteoporosis International 4/2009 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.